Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

15.96
+0.25801.64%
Volume:7.43M
Turnover:121.39M
Market Cap:5.58B
PE:-16.43
High:17.25
Open:15.37
Low:15.37
Close:15.70
52wk High:24.28
52wk Low:1.53
Shares:349.76M
Float Shares:291.15M
Volume Ratio:1.94
T/O Rate:2.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:15.42
PE(LYR):-36.33

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Reuters
·
Apr 28

Erasca falls -46.0%

TIPRANKS
·
Apr 28

Erasca Down Over 50%, On Pace for Record Percent Decrease -- Data Talk

Dow Jones
·
Apr 28

Erasca Shares Down 46.4% After Patient Death in Early-Stage Cancer Drug Trial

THOMSON REUTERS
·
Apr 28

Erasca falls after disclosing patient died after withdrawing from trial

TIPRANKS
·
Apr 28

Top Premarket Decliners

MT Newswires Live
·
Apr 28

BUZZ-U.S. STOCKS ON THE MOVE-UPS, Centene, Coca-Cola

Reuters
·
Apr 28

Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20

TIPRANKS
·
Apr 28

BUZZ-Erasca drops after patient death reported in early cancer trial

Reuters
·
Apr 28

Erasca Shares Down 36.6% Premarket; Co Announces Early-Stage Trial Results for Experimental Cancer Treatment

THOMSON REUTERS
·
Apr 28

Stock Track | Erasca Plunges 34.78% in Pre-market Following Patent Infringement Allegations by Revolution Medicines

Stock Track
·
Apr 28

Stock Track | Erasca Plunges 30.08% in Overnight Trading Following Patent Infringement Allegations by Revolution Medicines

Stock Track
·
Apr 28

24H | Sanmina Surges 14%; Nucor Jumps 5%; Bloom Energy Gains 4%; Nvidia Rises 1%; Celestica Drops 8%; Rambus Sinks 11%

Tiger Newspress
·
Apr 28

Stocks to Watch: Bed Bath & Beyond, Erasca, Simpson Manufacturing, LendingClub

Dow Jones
·
Apr 28

Erasca Shares Tumble, Revolution Medicines Alleges Cancer Drug Patent Infringement

Dow Jones
·
Apr 28

Erasca Reports Encouraging Phase 1 Data for ERAS-0015

TIPRANKS
·
Apr 28

Erasca Inc - Announces Positive Preliminary Phase 1 Data for Eras-0015 in Ras-Mutant Solid Tumors

THOMSON REUTERS
·
Apr 28

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

GlobeNewswire
·
Apr 28

Erasca believes Revolution infringement claims ‘without merit,’ says Stifel

TIPRANKS
·
Apr 27

Mizuho Raises Price Target on Erasca to $28 From $19, Keeps Outperform Rating

MT Newswires Live
·
Apr 27